just a reminder the last 2 PRs' issued out of mgmt
Post# of 72440
April 16, 2018
INNOVATION PHARMACEUTICALS DATA FROM PHASE 2 BRILACIDIN ORAL MUCOSITIS (OM) TRIAL IN HEAD AND NECK CANCER SHOW NOTABLE REDUCTIONS IN MEDIAN DURATION OF SEVERE OM AND IN NUMBER OF UNPLANNED VISITS...
April 9, 2018
INNOVATION PHARMACEUTICALS PHASE 2 ORAL MUCOSITIS TRIAL ADDITIONAL DATA SHOW BRILACIDIN-OM DEMONSTRATED A SIGNIFICANT REDUCTION IN THE INCIDENCE OF SEVERE ORAL MUCOSITIS...
http://www.ipharminc.com/press-release/
http://www.ipharminc.com/financials/
Date Open High Low Close* Adj Close** Volume
Apr 18, 2018 0.4900 0.5000 0.4600 0.4700 0.4700 270,700
Apr 17, 2018 0.5300 0.5300 0.4800 0.4900 0.4900 265,900
Apr 16, 2018 0.5100 0.5100 0.4800 0.5000 0.5000 296,000
Apr 13, 2018 0.5000 0.5300 0.4900 0.5100 0.5100 181,000
Apr 12, 2018 0.5500 0.5500 0.5000 0.5100 0.5100 198,200
Apr 11, 2018 0.5900 0.5900 0.5200 0.5300 0.5300 172,300
Apr 10, 2018 0.6000 0.6300 0.5700 0.5700 0.5700 116,100
Apr 09, 2018 0.6100 0.6300 0.5500 0.5800 0.5800 391,300
https://finance.yahoo.com/quote/IPIX/history?p=IPIX
4kids